This retrospective study investigated the impact of neoadjuvant chemotherapy on the number of lymph nodes harvested in patients with T3/T4 gastric cancer. Lymph node counts in 58 patients who received preoperative neoadjuvant chemotherapy were compared with those in 168 patients who received surgery alone. Significantly more patients (n = 14, 24.1%) treated with neoadjuvant chemotherapy had < 15 lymph nodes harvested compared with patients (n = 13, 7.7%) treated with surgery alone. A significant correlation between the total number of harvested lymph nodes and the number of metastatic lymph nodes (mLNs) existed in both groups. Neoadjuvant chemotherapy was the only factor associated with the retrieval of < 15 lymph nodes. The number of mLNs was an independent predictive factor for overall survival. Although neoadjuvant chemotherapy decreased the number of lymph nodes harvested, the number of mLNs may still be an acceptable prognostic factor in patients with gastric cancer, following neoadjuvant chemotherapy.
LeungWKWuMSKakugawaY: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol2008; 9: 279–287.
2.
CunninghamDAllumWHStenningSP: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med2006; 355: 11–20.
3.
SpizzoGÖfnerDde VriesA: Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study. Ann Surg Oncol2001; 18: 677–683.
4.
WangAGuoPSunZ: Clinicopathological variables associated with lymph node metastasis and prognostic factors in pT2 gastric cancer. J Int Med Res2009; 37: 359–366.
5.
CoimbraFJCostaWLJrMontagniniAL: The interaction between N-category and N-ratio as a new tool to improve lymph node metastasis staging in gastric cancer: results of a single cancer center in Brazil. Eur J Surg Oncol2011; 37: 47–54.
6.
LiuCLuYJunZ: Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosa. Surg Oncol2009; 18: 379–384.
7.
GiulianiACaporaleACoronaM: Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count. J Exp Clin Cancer Res2004; 23: 215–224.
8.
ShenJYKimSCheongJH: The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer. Cancer2007; 110: 745–751.
BélangerJSoucyGSidérisL: Neoadjuvant chemotherapy in invasive breast cancer results in a lower axillary lymph node count. J Am Coll Surg2008; 206: 704–708.
11.
DollDGertlerRMaakM: Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg2009; 33: 340–347.
12.
Luna-PérezPRodríguez-RamírezSAlvaradoI: Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Res2003; 34: 281–286.
13.
World Health Organization (WHO): WHO Handbook for Reporting Results of Cancer Treatment. WHO offset publication No. 48. Geneva: World Health Organization, 1979 (available at: http://whqlibdoc.who.int/offset/WHO_OFFSET_48.pdf).
14.
WaneboHJKennedyBJWinchesterDP: Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on long-term survival. J Am Coll Surg1997; 185: 177–184.
15.
ShenJGCheongJHHyungWJ: Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion. Am J Surg2006; 192: 301–305.
16.
NeumanHCareyLAOllilaDW: Axillary lymph node count is lower after neoadjuvant chemotherapy. Am J Surg2006; 191: 827–829.
17.
BaslaimMMAl MalikOAAl SobhiSS: Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy. Am J Surg2002; 184: 299–301.
18.
CilTHauspyJKahnH: Factors affecting axillary lymph node retrieval and assessment in breast cancer patients. Ann Surg Oncol2008; 15: 3361–3368.
19.
LindebjergJSpindlerKLPloenJ: The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Colorectal Dis2009; 11: 264–269.
20.
KlosCLBordeianouLGSyllaP: The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery. Dis Colon Rectum2011; 54: 171–175.
21.
Habr-GamaAPerezROProscurshimI: Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean?Dis Colon Rectum2008; 51: 277–283.
22.
OttKSendlerABeckerK: Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: A prospective phase II study. Gastric Cancer2003; 6: 159–167.
23.
HeRBChenJQ: Pre-operative chemotherapy for gastric cancer. J Int Med Res2009; 37: 1259–1266.
24.
RougierPLasserPDucreuxM: Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol1994; 5: 59–68.
25.
AurelloPD'AngeloFRossiS: Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg2007; 73: 359–366.
